Evaluating Re-Identification Risks scores in Publicly Available Clinical Trial Datasets: Insights and Implications.

Activity: Academic talk or presentation types › Oral presentation

Description

Oral presentation at the Statisticians in the Pharmaceutical Industry (PSI) 2024 conference (Amsterdam, June 2024).
Period6 Jun 2024
Held atStatisticians in the Pharmaceutical Industry (PSI), United Kingdom